Try our Advanced Search for more refined results
Searching dockets in Biocon Ltd x
Alert me of new activity
All Case Activity Alerts Include: Answers, Appeals, Complaints, Motions, Orders, Trial Notes
830 Patent | West Virginia Northern
Motion
MOTION for Leave to File UNDER SEAL by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment Memorandum in Support)Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00039-TSK-JPM, 1:25-cv-00074-TSK-JPM(Pogue, David) (Entered: 07/06/2026)
Patent | Massachusetts
Order ~Util - Set Hearings
Judge George A. OToole, Jr: ELECTRONIC ORDER entered ACKNOWLEDGING 134 Joint Status Report. The request to extend the discovery deadline is denied without prejudice at this time. The upcoming telephone status conference is continued to September 15, 2026, at 11:30 a.m. On or before seven days before the conference, the parties shall confer and submit a detailed joint status report. To the extent the parties believe additional deadlines are necessary at that point, they shall propose a joint schedule. ELECTRONIC NOTICE OF RESCHEDULING: Telephone Status Conference reset for 9/15/2026 at 11:30 AM in Remote Proceeding : Boston before Judge George A. OToole Jr. Call-in number is 1-650-479-3207; Access code: 23161815049.(TRM)
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login
Email (NOTE: Free email domains not supported)
First Name
Last Name
Job Title
PLEASE NOTE: A verification email will be sent to your address before you can access your trial.
Password (at least 8 characters required)
Confirm Password
Law360 may contact you in your professional capacity with information about our other products, services and events that we believe may be of interest.You’ll be able to update your communication preferences via the unsubscribe link provided within our communications.We take your privacy seriously. Please see our Privacy Policy.